Sponsor:
M.D. Anderson Cancer Center
Code:
NCT04474301
Conditions
COVID-19 Infection
Melanoma
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Not accepted
Interventions
Survey Administration
Brief summary:
Conditions
COVID-19 Infection
Melanoma
Study ID
NCT04474301
Start date
Jun 11, 2020
Status verified date
Apr, 2026
Completion date
Dec 30, 2026
Anticipated
Primary completion date
Dec 30, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Not accepted
Enrollment
1152 participants
Anticipated
Arms
Observational (survey administration)
Interventions
Survey Administration
Primary outcome measure
Central contacts
Locations
M D Anderson Cancer Center
Recruiting
Houston, Texas, United States, 77030
Contacts
Lorenzo Cohen
lcohen@mdanderson.orgPrincipal Investigator:
Lorenzo Cohen
Sponsor
M.D. Anderson Cancer Center
Last update posted
Apr 16, 2026
Last verified
Apr, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2026-04-16.